Nationwide survey exposes a heavy burden of hypertension and diabetes in Bangladeshi adults

Bangladesh is facing a growing chronic disease burden that now cuts across age, sex, and socioeconomic lines. In a nationwide analysis of adult biomarker data from the 2011 Bangladesh Demographic and Health Survey, hypertension, diabetes, and their comorbidity emerged as common and unevenly distributed conditions, with clear differences in who was affected and who was able to access care. The study included 7,521 adults with biomarker information, and the mean age was 51.4 years, a reminder that this was not a sample of the very old alone but a broad adult population already carrying substantial cardiometabolic risk.

The prevalence figures were striking in their own right. Hypertension affected 29.7% of participants, diabetes 11.0%, and comorbidity 4.5%. Those rates place blood pressure and glucose disorders firmly among the dominant noncommunicable disease problems in the population studied. A single survey cannot capture every dimension of disease progression, but it can reveal the scale at which silent vascular and metabolic injury is accumulating before clinical complications become visible in routine care.

Age, education, employment, and region shaped the odds of disease

Age exerted the clearest effect. Adults older than 70 years had a sharply higher likelihood of hypertension and comorbidity, with adjusted odds ratios of 7.0 and 6.7, respectively. The size of those associations reflects the cumulative biology of vascular aging: arterial stiffening, endothelial dysfunction, and long-term exposure to metabolic stress all converge over decades to push blood pressure and glucose control in the wrong direction.

A single age threshold did not explain the whole pattern. Higher education, unemployment, and residence in Khulna division were all linked to a greater risk of hypertension, diabetes, and comorbidity. The direction of the education association may appear counterintuitive at first glance, but in cross-sectional population data it often signals complex social transition, urban lifestyle change, dietary shifts, lower physical activity, and longer survival into ages when chronic disease becomes more likely to be detected. Employment status and geography add another layer. Economic inactivity can limit routine health-seeking and physical conditioning at the same time, while regional differences may reflect variations in diet, healthcare access, or local risk environments.

Sex-specific reporting was central to the study question, and the analysis was designed to examine differences between men and women rather than treating the adult population as a single undifferentiated group. Although the abstract does not provide separate prevalence percentages by sex, the framing matters clinically because cardiometabolic risk, health-seeking behavior, and access to diagnosis often diverge along gender lines long before complications are documented in hospital records.

Inequality in care use mirrors the disease burden itself

The study did not stop at prevalence. It also assessed inequality in healthcare utilisation using the Lorenz curve, a method more often used to describe concentration of wealth or resources but highly relevant when access to chronic disease care is uneven. The analysis found socioeconomic inequality in the use of healthcare services, meaning that the people most likely to carry the burden of hypertension and diabetes were not necessarily those most likely to receive evaluation or ongoing management.

One sentence captures the clinical consequence: disease burden and service access were not aligned. When diagnosis and treatment depend on income, education, or where a person lives, chronic disease becomes more dangerous because it remains untracked for longer and is less likely to be controlled before stroke, kidney injury, retinopathy, or cardiovascular events develop.

The public health implication is straightforward. Hypertension and diabetes do not behave as isolated diagnoses in low-resource settings; they function as linked drivers of cardiovascular and renal harm, and when they coexist, risk rises further. A 4.5% comorbidity prevalence may appear smaller than the prevalence of either disease alone, but comorbidity is the more clinically consequential state because it signals overlapping vascular injury and greater downstream treatment complexity.

What the biomarker findings mean for frontline care

Because the study drew on biomarker data rather than self-report alone, it offers a more reliable picture of hidden disease than symptom-based surveys would have provided. Many adults with hypertension or diabetes do not present until complications appear, especially where screening is inconsistent or healthcare costs delay routine visits. Biomarker-based prevalence estimates therefore have immediate value for health planners: they show the burden that is already present, not merely the burden that has been diagnosed.

The association with Khulna division suggests that geography still matters in chronic disease epidemiology, even within a single national survey. Regional differences can reflect food systems, population density, access to screening, and local patterns of lifestyle change. In practical terms, a national noncommunicable disease strategy cannot rely on uniform messaging alone; it must be adapted to where risk clusters and where healthcare contact is least reliable.

Several results also point to the need for integrated screening. Hypertension and diabetes frequently travel together through the same pathways of insulin resistance, vascular dysfunction, and kidney stress. If one condition is found, the other should be assessed, especially in older adults and in communities where healthcare use is uneven. In settings like Bangladesh, a fragmented approach risks missing comorbidity until the patient already has preventable end-organ damage.

Policy pressure points emerge from the cross-sectional data

The study’s authors called for a joint effort involving public, private, and nongovernmental organisations to improve access and reduce disease burden. The data support that direction. Chronic disease control in a country with a large adult population and widening cardiometabolic exposure cannot depend on opportunistic diagnosis alone. It requires screening pathways that reach older adults, unemployed adults, and communities with known access gaps, along with follow-up systems that do more than record a blood pressure or glucose value once.

Cross-sectional design limits causal inference, and the survey captures one time point rather than disease trajectories over years. Even so, the pattern is difficult to ignore: hypertension, diabetes, and comorbidity are common, their distribution is socially patterned, and service utilisation is unequal. Those features together describe a health system challenge that extends beyond individual behavior and into the structure of care delivery itself.

Bangladesh’s next step is not simply to count more cases. It is to detect them earlier, treat them more consistently, and make sure the people at highest risk are not the least able to reach care.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by BMJ Open.